Air Liquide SA · EURONEXT:AI
Air Liquide SA — FY2019 Earnings Presentation
50 slides from Air Liquide SA's earnings presentation, Feb 11, 2020
Slide 1: Full Year 2019 Results
Full Year 2019 Results Step-up in Performance Improvement High level of Investments for Customers and Efficiency Commitment to Climate Reaffirmed Paris, 11 February 2020 Tokyo Innovation Campus
Slide 2: 2019, A Landmark Year for Air Liquide
2019, A Landmark Year for Air Liquide Benoît Potier Chairman & Chief Executive Officer 2 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 3: 2019, A Landmark Year for Air Liquide
2019, A Landmark Year for Air Liquide • Commitment to a structured plan for performance improvement driving initial step up in margins • Commitment to customers and efficiency High level of investments, major signings in key basins • Commitment to climate reaffirmed Reduction in carbon intensity and
Slide 4: Strong Performance Improvement in 2019
Strong Performance Improvement in 2019 Group Sales +4.3% + 70bps Operating Operating Income Recurring +10.0% Margin(1) Recurring Net Profit(2) +11.1% Recurring ROCE(3) +60bps (1) Excluding energy impact (2) Excluding exceptional and significant operations not impacting the Operating Income Recurring
Slide 5: Structured Program in Place to Deliver NEOS and Beyond
Structured Program in Place to Deliver NEOS and Beyond Reinforced Launched Extended existing plan in 2019 Outlook Pricing + Product Mix Management … with commitment to Efficiencies + Transformation Programs further improve the operating margin(1). Bolt-on Portfolio + Acquisitions Streamlining (1)
Slide 6: High Investments, Order Intake Recovering
High Investments, Order Intake Recovering Industrial Investment Decisions E&C and GM&T Order Intake €3.2bn GM&T E&C €1.4bn 3.5 1.5 3 1.2 2.5 2 0.9 1.5 0.6 1 0.3 0.5 0 0 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2016 2017 2018 2019 6 11 February 2020 FY 2019 Results A world leader in gases, t
Slide 7: Proposed Dividend Distribution in 2020
Proposed Dividend Distribution in 2020 +9.0% 20 years CAGR Including free shares attribution €2.70(2) every other year + 12.4% 2.4 2.0 Dividend(1) Strong dividend increase in € per share 1.6 1.2 Increase of nominal 0.8 Free share attribution 0.4 58% Payout Ratio 0.0 1999 2001 2003 2005 2007 2009
Slide 8: Further Reduction of Carbon Intensity
Further Reduction of Carbon Intensity 2019 Achievement Climate Objectives announced in Nov. 2018 6.3 4.6 Reduction of -30% Carbon intensity from 2015 to 2025 (kg CO2/€ EBITDA(1)) Initial Carbon Intensity Commitment in kg CO2/€ EBITDA(1) * 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 4.4 (1
Slide 9: Launch of Major Innovative Projects
Launch of Major Innovative Projects Low CO2 CCS(1) Green H2 H2 Mobility Production California MOU with Northern Electrolyzer thyssenkrupp Lights in Quebec Paris Consortia with Ports HyGreen ArcelorMittal of Antwerp and Provence Rotterdam China (1) Carbon Capture and Storage 9 11 February 2020 FY 201
Slide 10: Performance Improvement in FY 2019
Performance Improvement in FY 2019 Fabienne Lecorvaisier Executive Vice President & Chief Financial Officer 10 1126 April 2017 February 2020 H1FY 2017 Activity 2019 Results TheAworld worldleader leader in gases, technologiesand gases, technologies andservices servicesforfor Industry Industry and and
Slide 11: Step-up in Performance Improvement
Step-up in Performance Improvement As published figures Group Sales Performance OIR/sales CF/sales(1) ROCE(2) +4.3% 17.3% 22.2% 8.6% (1) Cash Flow from Operations before changes in Working Capital Requirement on Group Sales (2) Recurring ROCE, based on Recurring Net Profit 11 11 February 2020 FY 201
Slide 12: Regardless of the Environment, Robust FY Sales Growth
Regardless of the Environment, Robust FY Sales Growth FY Group Sales: +2.1% FX Impact -1.4% Energy Impact +0.4% Scope 12 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 13: Q4 2019 Market Trends to Continue in Q1 2020
Q4 2019 Market Trends to Continue in Q1 2020 Chemicals Soft Chemicals and Steel LI Oil & gas Sustained demand for Refining in Europe Steel New projects across markets Metal Fab. Construction Widening contrasts in markets: IM Energy - Growing Consumption and Technology sectors Foo
Slide 14: Q4 – Stable Americas, Very Solid Europe
Q4 – Stable Americas, Very Solid Europe G&S comparable sales growth Americas – Major Customer Turnarounds in LI LI - customer turnarounds IM - solid pricing Sa les - widening contrasts in markets FY 2 0 1 9 - gas sales up, hardgoods down -9% €8,460m HC - strong Medical Gases in US and dynamic
Slide 15: Q4 – Solid Asia, Stable AME
Q4 – Solid Asia, Stable AME G&S comparable sales growth Asia – Robust EL, Solid LI, Resilient IM LI - O2 Ramp-Ups in China for Chemicals IM - China: strong cylinder volumes, lower Sa les bulk pricing FY 2 0 1 9 - strong helium sales €4,794m - slowing Australia and Japan EL - >+10% excluding E&
Slide 16: Q4 – Resilient IM, LI Stable Despite Turnarounds
Q4 – Resilient IM, LI Stable Despite Turnarounds G&S comparable sales growth Industrial Merchant – Sustained Pricing Compensating Lower Volumes Sales solid pricing at +3.2% FY 2 0 1 9 growing gas sales; drop in hardgoods €9,754m unequal end markets: - Strong Food, Pharma, and Techno - Weak Con
Slide 17: Q4 – Consistent High HC, Strong EL Excluding E&I
Q4 – Consistent High HC, Strong EL Excluding E&I G&S comparable sales growth Healthcare – Strong Organic Growth Sa les strong HHC across Europe, FY 2 0 1 9 expansion in diabetes €3,693m solid Medical Gases in Americas Electronics – +6.8% Growth Excluding E&I Sa les FY 2 0 1 9 double digit grow
Slide 18: Confirmed Step-Up in OIR Margin: +70 bps
Confirmed Step-Up in OIR Margin: +70 bps including +10bps from IFRS 16 18 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 19: Structured Performance Improvement Program
Structured Performance Improvement Program (1) +70bps OIR margin Price/Mix Efficiencies Portfolio Management (1) Operating Income on sales excluding energy impact in FY 2019 19 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 20: Pursued Management of Pricing and Product Mix
Pursued Management of Pricing and Product Mix IM pricing momentum Q4 margin contributors • Focus on high value added applications +3.3% +3.2% • Higher cylinder growth compared to bulk in IM +1.7% • Less E&I in EL and hardgoods in IM +0.9% • High helium pricing continuing in 2020 • 2020 Price campaig
Slide 21: Strengthened Efficiency Program Delivering
Strengthened Efficiency Program Delivering 2019 Cumulated efficiencies efficiencies € 433m On top of existing procurement €1.1bn and industrial efficiencies: +23% Pursued digital deployment with strong momentum in LI On-going reorganizations 2017-2020 especially in IM and HHC Europe >€ 1.5bn A
Slide 22: Continuous Portfolio Management
Continuous Portfolio Management Focus on Core business Densification of operations 6 Divestitures in 2019 24 Acquisitions in 2019 including 2 in Europe 4 at Airgas and 1 in Asia: Fujian 6 in China 2 at Airgas, 1 in Asia 1 in Canada and 1 in UK On-going 1 in Netherlands 9 including potential sale
Slide 23: Strong Recurring Net Profit
Strong Recurring Net Profit Recurring Net profit +11.1% Excluding one-offs: - Fujian in 2019 - financial gain in 2018 23 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 24: High Cash Flow and Gearing Reduction
High Cash Flow and Gearing Reduction Gearing Cash Flow Gearing 69% 22.2% of sales(3) 64% Net Debt Net Debt 31 Dec. 2018 31 Dec. 2019 (1) Including acquisitions, transactions with minority shareholders, net of divestitures (2) Including share purchases and capital increases (3) 21.0% excluding IFRS16
Slide 25: Regular ROCE Improvement
Regular ROCE Improvement ROCE – After tax 10.3% >10% 10% +60bps 8.6%(2) 8.0% 8% 7.7%(1) 6.9% 6% Dec. 15 Dec. 16 Dec. 17 Dec. 18 Dec. 19 2021/22 2021/2022 adjusted NEOS Airgas objective acquisition (1) Excluding positive impact on 2017 net profit of non-cash one-off items (2) Recurring ROCE based on
Slide 26: High Level of Investments for Customers and Efficiency
High Level of Investments for Customers and Efficiency Investment Investment Start-up/Ramp-up Opportunities(1) Decisions(1) Sales Growth Contribution 12-month portfolio €2.9bn €3.7bn €336m FY 18 Q3 19 FY 19 FY 2018 FY 2019 FY 2018 FY 2019 • Mostly Chemicals, Oil & • Major signings in key basins • 18
Slide 27: Confirmed 2020 Estimated Contribution from Start-Ups
Confirmed 2020 Estimated Contribution from Start-Ups Major Start-Ups 2020 2019 Q1Q1 Q2Q2 Q3Q3 Q4Q4 LI LI EL LI LI LI EL EL Project Project Project Project Project Project Project Project Asia South Asia US Canada Europe Asia Asia America Sales growth contribution Increased Backlog €2.8bn ~€ 230m € 0
Slide 28: 2020 Outlook
2020 Outlook “Assuming no major change in the Diverse Resilient environment and the international End Business Markets Model health situation is under control, Air Liquide is confident in its ability to further increase its operating Strong Performance Investment Improvement margin and to deliver ne
Slide 29: FY 2019 Appendix
FY 2019 Appendix 29 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 30: FY 2019 G&S Revenue Breakdown by Region
FY 2019 G&S Revenue Breakdown by Region Europe €7.2bn Asia- Americas Pacific €8.5bn €4.8bn €21,040m Industrial Merchant Large Industries Healthcare Electronics 30 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 31: Americas
Americas Q4 Gas & Services Sales: €2,106m INDUSTRIAL MERCHANT LARGE INDUSTRIES HEALTHCARE ELECTRONICS • Widening contrasts between • Heavy customer turnarounds • Strong Medical Gases in • Strong Carrier Gases markets: in U.S.: -5% of Americas sales U.S. for Proximity care • High YoY E&I comparison -
Slide 32: Europe
Europe Q4 Gas & Services Sales: €1,819m INDUSTRIAL MERCHANT LARGE INDUSTRIES HEALTHCARE • Resilient activity in all • Solid H2 demand for • High organic growth in HHC with geographies refining in Benelux strong Diabetes • Solid pricing at +2.5% • Soft steel and chemicals • Solid Medical Gases and Hy
Slide 33: Asia-Pacific
Asia-Pacific Q4 Gas & Services Sales: €1,182m INDUSTRIAL MERCHANT LARGE INDUSTRIES ELECTRONICS • Recovering pricing: +1.4%, • O2 Ramp-Ups in China for • >+10% excluding E&I, especially incl. Helium Chemicals in China, Korea and Taiwan • China: strong cylinder volumes, • High H2 volumes in Singapore
Slide 34: Industrial Merchant Pricing
Industrial Merchant Pricing 34 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 35: FY 2019 E&C and GM&T Activities
FY 2019 E&C and GM&T Activities Engineering & Construction Global Markets & Technologies Sales to third parties(1) Sales(1) €328m -25% €552m +15% Total Sales(2) growing Order Intake Order Intake €838m +4% €523m +14% (1) Comparable growth (2) Including internal Sales 35 11 February 2020 FY 2019 Resul
Slide 36: Investment Backlog Increased to €2.8bn
Investment Backlog Increased to €2.8bn Decisions Start-ups €2.8bn €2.2bn €2.1bn €2.1bn in €bn € 0.9bn Dec 2016 Dec 2017 Dec 2018 Decisions Start-ups Dec 2019 Yearly Sales Backlog after full Ramp-ups See definitions in appendix 36 11 February 2020 FY 2019 Results A world leader in gases, technologies
Slide 37: G&S Quarterly Growth Analysis
G&S Quarterly Growth Analysis Base business (Mainly Tech Air) +0.2% (1) Comparable growth based on 2016 adjusted sales 37 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 38: Consolidated P&L
Consolidated P&L 38 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 39: Operating Margin (OIR/Revenue)
Operating Margin (OIR/Revenue) H1 2018 H2 2018 2018 Group 15.9% 16.9% 16.4% Gas & Services 17.8% 18.7% 18.3% H1 2019 H2 2019 2019 Group 16.6% 18.1% 17.3% Group - Excl. Energy 16.6% 17.6% 17.1% including +10bps from Gas & Services 18.4% 19.9% 19.1% IFRS 16 Gas & Services - Excl. Energy 18.4% 19.3% 18
Slide 40: Consolidated Balance Sheet Simplified - In €m
Consolidated Balance Sheet Simplified - In €m * Including fair value of derivatives 40 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 41: Cash Flow Statement
Cash Flow Statement * PPE: Property, plant and equipment. 41 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 42: Impact of Currency and Energy on G&S Revenue
Impact of Currency and Energy on G&S Revenue 42 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 43: Revenue Analysis by Quarter and by Business Line
Revenue Analysis by Quarter and by Business Line 43 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 44: Revenue Analysis by Quarter and by Geography
Revenue Analysis by Quarter and by Geography 44 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 45: G&S Revenue Growth by Quarter and by Impact
G&S Revenue Growth by Quarter and by Impact 45 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 46: Investment Cycle – Definitions
Investment Cycle – Definitions ● Investment opportunities at end of the period – Investment opportunities under consideration by the Group for decision within 12 months. – Industrial projects with investment value > €5m for Large Industries and > €3m for other business lines. – Includes asset replac
Slide 47: Financing Structure
Financing Structure As of December 31, 2019 > 5 years Between 1 and 5 years < 1 year (1) Others: put options granted to minority shareholders. 47 11 February 2020 FY 2019 Results A world leader in gases, technologies and services for Industry and Health
Slide 48: Regular and Sustained Performance
Regular and Sustained Performance CAGR over 30 years(1) 24,000 Revenue (in €m) +5.6% EPS(2) (in €) +6.7% 20,000 5.0 16,000 4.0 12,000 3.0 8,000 2.0 4,000 1.0 0 0.0 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2
Slide 49: Disclaimer
Disclaimer This presentation may contain forward-looking statements (including objectives and trends) about Air Liquide’s financial situation, operating results, business activities and strategy. Although Air Liquide believes that the expectation reflected in such forward-looking statements are reas
Slide 50: For further information, please contact: Investor Relations Communication
For further information, please contact: Investor Relations Communication Aude Rodriguez + 33 (0)1 40 62 57 08 Alexandra Rocca + 33 (0)1 40 62 50 93 Ludmilla Binet + 33 (0)1 40 62 57 37 Annie Fournier + 33 (0)1 40 62 51 31 Muriel Légeron + 33 (0)1 40 62 50 18 Pierre-Germain Marlier + 33